Hepatitis A as an etiologic agent of acute liver failure in Latin America

Pediatric Infectious Disease Journal

Volumn 26, Issue 8, 2007, Pages 711-715

  Ciocca, Mirta ^a   Moreira Silva, Sandra Fagundes ^b   Alegría, Sylvia ^c   Galoppo, Maria Cristina ^d   Ruttiman, Ricardo ^e   Porta, Gilda ^f   Da Silvera, Themis Reverbel ^g   Rubio, Pilar ^e   Macias, Mercedes ^h   Cervantes, Yolanda ^e   Avila Aguero, Maria Luisa ⁱ   Clemens, Sue Anne Costa ^j   Clemens, Ralf ^k   Weil, John ^e,l  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b Hospital Infantil NS da Gloria   (Brazil)

^c HOSPITAL ROBERTO DEL RÍO   (Chile)

^d Hospital de Niños Ricardo Gutierrez

^e GLAXOSMITHKLINE   (United Kingdom)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^h INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

ⁱ HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^j Instituto Carlos Chagas   (Brazil)

^k GSK Biologicals Latina   (Brazil)

^l GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

more..

Author keywords

Acute liver failure; Hepatitis A; Viral hepatitis

Indexed keywords

HEPATITIS B ANTIBODY; IMMUNOGLOBULIN M; MEMBRANE ANTIGEN;

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; BRAZIL; CHILD; CHILE; CLINICAL TRIAL; COHORT ANALYSIS; COLOMBIA; CONTROLLED STUDY; COSTA RICA; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS VIRUS; HOSPITAL PATIENT; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SOUTH AND CENTRAL AMERICA; VIRUS INFECTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS B ANTIBODIES; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN M; INFANT; LATIN AMERICA; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; PREVALENCE; PROSPECTIVE STUDIES;

EID: 34548810948     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e3180f60bed     Document Type: Article

References (33)

1. Graig JG, Bryan JP, Miller RE, et al. The prevalence of hepatitis A, B and C infection among different ethnic groups in Belize. Am J Trop Med Hyg. 1993;49:430-434.
2. Fay OH, Hadler SC, Maynard JE, Pinhero F. Hepatitis in the Americas. Bull Pan Am Health Organ. 1988;19:401-405.
3. Villarejos VM, Provost PG, Ittensohn OL, Mc Lean AA, Hilleman AR. Seroepidemiological investigation of human hepatitis caused by A, B and a possible third virus. Proc Soc Exp Biol Med. 1976;132:524-528.
4. Perez CA, Oviedo J, Gonzalez ML. Evaluacion de hepatitis virales agudas asistidas en un hospital zonal. Acta Gastroenterol Latinoam. 1992;22:239-242.
5. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine. 1992;10:S56-S62.
6. Debray D, Cullufi P, Devictor D, Fabré M, Bernard O. Liver failure in children with hepatitis A. Hepatology. 1997;26:1018-1022.
7. Ciocca M, Ramonet M, Cuarterolo, et al. Fulminant hepatic failure for viral hepatitis in children [abstract 316]. IX triennial international symposium on viral hepatitis and liver disease. Rome. 1996;21-25.
8. Zacarias J, Brinck P, Cordero J, Velasco M. Etiologies of fulminant hepatitis in pediatric patients in Santiago de Chile. Pediatr Infect Dis J. 1987;6:686-687.
9. Moreira-Silva SF, Frauches DO, Almeida AL, Mendonca HF, Pereira FE. Acute liver failure in children: observations in Vitoria, Espirito Santo State Brazil. Rev Soc Bras Med Trop. 2002;35:483-486.
10. Friedland IR, Zuckerman MB, Kala UK, Parbhoo KB. Fulminant hepatitis in children: report of 12 cases. Ann Trop Paediatr. 1991;11:207-211.
11. Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18:S71-S74.
12. O'Grady J. Management of acute and fulminant hepatitis A. Vaccine. 1992;10(S1):S21-S23.
13. Bendre SV, Bavdekar AR, Bhave SA, Pandit AN, Chitambar SD, Arankalle VA. Fulminant hepatic failure: etiology, viral markers and outcomes. Indian Pediatr. 1999;36:1107-1112.
14. Shah U, Habib Z. Liver failure attributable to hepatitis A virus infection in a developing country. Pediatrics. 2000;104:436-438.
15. O'Grady JS, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273-275.
16. Devictor D, Desplanques L, Debray D, et al. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology. 1992;16:1156-1162.
17. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep. 1997;46 (RR-10).
18. Arora NK, Nanda SK, Gulati S, et al. Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol. 1996;48:215-221.
19. Williams E, Questa H, Wacholder V, et al. Development of a paediatric liver transplantation program in Argentina. Pediatr Surg Int. 1998;13:319-322.
20. World Health Organization (WHO). Vaccine-preventable diseases: monitoring system 2005 global summary. Available at: http://www.who.int/vaccines-. documents/GlobalSummary/GlobalSummary.pdf. 2005.
21. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology. 1995;21:240-252.
22. Farci P, Alter HJ, Shimoda A, et al. Hepatitis C virus associated fulminant hepatic failure. N Engl J Med. 1996;335:631-634.
23. Liang TJ, Jeffers L, Reddy RK, et al. Fulminant or subfulminant non-A non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology. 1993;104:556-562.
24. Alvarez-Munoz MT, Torres J, Damasio L, Gomez A, Tapia-Conyer R, Munoz O. Seroepidemiology of hepatitis E virus infection in Mexican subjects 1 to 29 years of age. Arch Med Res. 1999;30:251-254.
25. Bortoliero AL, Bonametti AM, Morimoto HK, Matsuo T, Reiche EM. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the regional blood bank of Londrina, State of Parana, Brazil. Rev Inst Med Trop Sao Paulo. 2006;48:87-92.
26. Tapia-Conyer R, Santos JI, Cavalcanti AM, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg. 1999;61:825-829.
27. Vitral CL, Gaspar AM, Souto FJ. Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002 - a review. Mem Inst Oswaldo Cruz. 2006;101:119-127.
28. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine. 2000;18:S57-S60.
29. Ruttimann RW, Clemens RL. Argentine and Latin American hepatitis A. J Travel Med. 2002;9:220.
30. Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile. Vaccine. 2005;23:4110-4119.
31. Wasley A, Samandari T, Bell BP. Hepatitis A in the United States in the era of vaccination. JAMA. 2005;294:194-201.
32. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA. 2005;294:202-210.
33. World Health Organization. Hepatitis A vaccines WHO position paper. Wkly Epidemiol Rec. 2000;75:38-44.